A newly available Tracker-325 catheter (Target Therapeutics, Fremont,
CA, USA), modified from the Tracker-18 catheter, has the same outer di
ameter but a larger lumen. This catheter was used in 15 patients durin
g a 7-month period for superselective arterial catheterization when co
nventional catheters could not be placed successfully. Arterial emboli
zation (n = 7), chemoembolization (n = 5), and chemoinfusion (n = 3),
were performed. The increased luminal diameter of the Tracker-325 allo
wed an increased flow rate for diagnostic arteriography, accommodated
larger embolic particles, and improved the ability to achieve a supers
elective position.